Cambridge Healthtech Institute is proud to announce the Molecular Med Tri-Con taking place in San Francisco, California. Last year’s event was the largest in its history with growth in the conference agenda, record attendance (3,000+ participants) and an unprecedented number of sponsors and exhibitors (140+ unique organizations).
CHI has built its success and reputation on the fact that “content is king.” This year’s event will deliver 20 focused core programs on diagnostics, therapeutics, clinical trials and sequencing, informatics, and cancer. NEW core programs and symposia ensure you are seeing NEW prospects in 2014! Participants will include C-level executives, directors and managers from leading biotech and pharma organizations.
Exhibitors will enjoy facilitated networking opportunities with 3,000+ high-level conference delegates. Speak face-to-face with prospective clients and showcase your latest product, service, or solution.
How will CHI ensure that all delegates visit the exhibit hall?
Dedicated exhibit hall hours during key session breaks with refreshments served
Renowned keynote speakers drawing high-level attendees
Opening night cocktail reception held in exhibit hall
Scientific posters on display and awards presented in exhibit hall
Judging of Poster Award inside the exhibit hall
Awarding raffle prizes (iPads, Wii, iPods, etc.) inside the exhibit hall
Leading vendors presenting scientific and technological solutions at Vendor Theatre in the hall
Aggressive exhibit hall pass marketing campaigning to attract targeted prospects from the San Francisco area
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, lnsight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.